Bio-Rad Laboratories Stock (NYSE: BIO) stock price, news, charts, stock research, profile.
Open | $286.040 |
Close | $285.280 |
Volume / Avg. | 250.549K / 209.496K |
Day Range | 284.045 - 294.330 |
52 Wk Range | 261.590 - 473.500 |
Market Cap | $8.136B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NYSE |
RSI | 36 |
Short Interest | 3.17% |
Days to Cover | 3.2 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Bio-Rad Laboratories (NYSE: BIO) through any online brokerage.
Other companies in Bio-Rad Laboratories’s space includes: Medpace Hldgs (NASDAQ:MEDP), Agilent Technologies (NYSE:A), 10x Genomics (NASDAQ:TXG), Waters (NYSE:WAT) and Olink Holding (NASDAQ:OLK).
The latest price target for Bio-Rad Laboratories (NYSE: BIO) was reported by Citigroup on Wednesday, April 3, 2024. The analyst firm set a price target for 365.00 expecting BIO to rise to within 12 months (a possible 27.94% upside). 11 analyst firms have reported ratings in the last year.
The stock price for Bio-Rad Laboratories (NYSE: BIO) is $285.28 last updated April 23, 2024 at 4:00 PM EDT.
A quarterly cash dividend of $0.00 per share of Class A Common Stock. The quarterly cash dividend was payable on Invalid DateTime to stockholders of record on Invalid DateTime.
Bio-Rad Laboratories’s Q1 earnings are confirmed for Tuesday, May 7, 2024.
There is no upcoming split for Bio-Rad Laboratories.
Bio-Rad Laboratories is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NYSE.